Targeted Oncology interviews feature the world's leading oncologists sharing their insights on the latest news and advances in diagnostic testing, biomarkers, pathways, immunotherapy, and targeted therapeutics for better application into clinical practice.
Dr. Steinberg on Impact of Immunotherapy on Renal Cell Carcinoma
October 6th 2015Gary D. Steinberg, MD, Bruce and Beth White Family Professor, professor of Surgery, director, Urologic Oncology, University of Chicago Medicine, discusses the potential of immunotherapy on the treatment of renal cell carcinoma.
Read More
Dr. Pavlick on the Importance of Tumor Biopsies in Melanoma
October 6th 2015Anna C. Pavlick, DO, co-director, Melanoma Program, assistant director, Clinical Research Education, associate professor, Departments of Medicine and Dermatology, Langone Medical Center, New York University, discusses the benefits of biopsying melanoma tissue before treatment to better target therapy.
Read More
Dr. Pelosof on Therapies for Never Smokers With NSCLC
October 2nd 2015Lorraine Pelosof, MD, PhD, assistant professor, Division of Hematology/Oncology, The University of Texas Southwestern Medical Center, discusses targets and possible therapies for never smokers diagnosed with non-small cell lung cancer (NSCLC).
Read More
Dr. Frederic Amant on the Safety of Chemotherapy During Pregnancy
October 1st 2015Frederic Amant, MD, PhD, assistant professor, gynecologic oncologist, head of the scientific section of gynecologic oncology at Katholieke Universiteit in Leuven, Belgium, the impacts of chemotherapy on pregnant woman and their babies.
Watch
Dr. Christiane Kuhl Discusses Breast MRI Screening of Women at Average Risk of Breast Cancer
October 1st 2015Christiane K. Kuhl, MD, Department of Diagnostic and Interventional Radiology, RWTH University of Aachen, discusses an observational cohort study looking at breast MRI screening of women at average risk of breast cancer.
Watch
Dr. Eggener Discusses Racial Disparities in Prostate Cancer
September 15th 2015Scott Eggener, MD, associate professor of surgery, co-director, Prostate Cancer Program, director, Transitional and Outcomes Research, Section of Urology, The University of Chicago Medicine, discusses racial disparities in men with prostate cancer.
Watch
Dr. Loeb Discusses the Controversy of Screening and Treatment in Prostate Cancer
September 10th 2015Stacy Loeb, MD, assistant professor, Urology and Population Health, NYU Langone Medical Center, discusses the controversy of screening and treatment in men with prostate cancer, as well as data from the National Prostate Cancer Register (NPCR) of Sweden.
Watch
Dr. Taylor Discusses the Toxicities and Impact of Lenvatinib in the SELECT Trial
September 1st 2015Matthew H. Taylor, MD, Oregon Health and Science University, discusses the toxicities and impact of lenvatinib in the SELECT trial, which treated patients with 131I-refractory differentiated thyroid cancer.
Watch
Dr. Hamilton Discusses Challenges With Approved Treatments for HER2-Positive Breast Cancer
August 28th 2015Erika P. Hamilton, MD, associate director, Breast Cancer and Gynecologic Cancer Research Program, principal investigator, Sarah Cannon Research Institute, discusses the challenges associated with utilizing new agents in HER2-positive breast cancer.
Watch
Dr. Petrylak Discusses BCG for the Treatment of Patients With Non-Invasive Bladder Cancer
August 28th 2015Daniel P. Petrylak, MD, professor of Medicine (Medical Oncology) and of Urology, co-director, Signal Transduction Research Program, Yale Cancer Center, discusses bacillus calmette-guerin (BCG) therapy for the treatment of patients with non-invasive bladder cancer.
Watch